Trademark: 76491276
Word

Status
Dead
Status Code
710
Status Date
Friday, October 19, 2012
Serial Number
76491276
Registration Number
3068626
Registration Date
Tuesday, March 14, 2006
Mark Type
2000
Filing Date
Friday, February 21, 2003
Published for Opposition
Tuesday, August 3, 2004
Cancellation Date
Friday, October 19, 2012

Trademark Owner History
Kyowa Hakko Kogyo Co., Ltd. - Original Registrant

Classifications
1 Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for scientific laboratory or medical research; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for scientific, laboratory or medical research; host cells for scientific, laboratory or medical research
5 Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for clinical or medical use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for clinical or medical use; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for clinical or medical use; host cells for clinical or medical use; pharmaceuticals, namely, central nervous system depressants; preparations for ophthalmic use, anti-histaminics; cardiotonics; arrhythmia treating agents; diuretics; hypotensors; prophylactic for the treatment of asthma; antitussives and expectorants; stomachics and digestives; antacids; hormones, namely, pituitary hormones for the treatment of infertility; thyroid hormones for the treatment of hyperthyroidism; anabolic hormones for the treatment of a plastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics; analgesics; anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents for treating vitamin deficiencies; anti-coagulants; enzyme preparations for control of malabsorption and diarrhea; anti-cancer preparations; anti-sarcoma preparations; antibiotics and their preparations for the treatment of infectious diseases; antituberculotic agents; influenza vaccines; diphtheria vaccines; tetanus vaccines; gas gangrene vaccines, Japanese encephalitis vaccines; in vitro tetrodotoxines for medical use; antiprotozoals for the treatment of trichomoniasis and dermatophytosis; anthelmintics for the treatment of thread worm and toxoplasmaosis; naturally occurring drugs for treating peptic ulcers; charred drugs for treating peptic ulcers; moxa for treating peptic ulcers; veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use; antiseptics; drugs for arteriosclerosis; oncostatic drugs for the treatment for cancer; multi enzyme digestants for in vivo use; anti fungal antibiotics for treating trichomoniasis and dermatophytosis; antiparkinsonism drugs; minor tranquilizers; and anti anxiety agents; medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; vitamins; anti-bacterial preparations; mucolytic preparations; medicinal preparations for the treatment of peptic ulcers; anti-inflammatory preparations; analgesic preparations; cephalosporin; cocarboxylase preparations; gluthathione preparations; preparations for improving the metabolism and the peripheral circulation; plasma substitutes and extra corporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro X-ray contrast agents for medical use, in vitro diagnostic media; pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
40 Custom manufacturing of antibody, fragment of antibody or derivatives of antibody; custom manufacturing of cells that manufactures antibody, fragment of antibody or derivatives of antibody; custom manufacturing of transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; custom manufacturing of host cells
42 Contract development for antibody, fragment of antibody or derivatives of antibody; contract development for cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for host cells
The mark is entirely in the color green.

Trademark Events
Oct 19, 2012
Cancelled Sec. 8 (6-Yr)
Jan 13, 2010
Teas Change Of Correspondence Received
Mar 14, 2006
Registered-Principal Register
Jan 31, 2006
Law Office Registration Review Completed
Jan 20, 2006
Assigned To Lie
Jan 19, 2006
Allowed Principal Register - Sou Accepted
Dec 7, 2005
Statement Of Use Processing Complete
Nov 10, 2005
Use Amendment Filed
Nov 10, 2005
Paper Received
May 10, 2005
Noa Mailed - Sou Required From Applicant
Mar 2, 2005
Extension Of Time To Oppose Process - Terminated
Sep 2, 2004
Extension Of Time To Oppose Received
Aug 3, 2004
Published For Opposition
Jul 14, 2004
Notice Of Publication
May 18, 2004
Approved For Pub - Principal Register
May 3, 2004
Examiners Amendment Mailed
Feb 10, 2004
Correspondence Received In Law Office
Feb 10, 2004
Paper Received
Aug 12, 2003
Non-Final Action Mailed
Aug 8, 2003
Assigned To Examiner
Mar 20, 2003
Paper Received

Trademark Alertz updated from USPTO on 2030-01-24